256840.KQ
BNC Korea Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 2,620.00
−1.50%Margins
Gross margin
35.1%
EBITDA margin
8.1%
EBIT margin
-6.5%
Net margin
-5.2%
FCF margin
3.2%
-2.1%
Return on equity
-1.7%
Return on assets
-2.3%
Return on invested capital
0.33x
Asset turnover
KRW 7.9B
Cash from operations
KRW 1.5K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026